Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CAN-3110
i
Other names:
CAN-3110, rQNestin34.5v.2, rQNestin-34.5, rQNestin 34.5, rQnestin-34.5v.2, rQNestin
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Candel Therap
Drug class:
Cytotoxic T lymphocyte stimulant
Related drugs:
‹
tretinoin (6)
DOC1021 (1)
INO-5401 (1)
GL-ONC1 (1)
cytotoxic lymphocyte-based cancer vaccine (0)
CRX100 (0)
EO2401 (0)
EO2463 (0)
ET140203 (0)
GRANITE (0)
GSK2130579A (0)
GSK2302025A (0)
GX301 (0)
HA-1 T TCR T Cell Immunotherapy (0)
HSV G207 (0)
IMA-901 (0)
IMA910 (0)
MT-201 (0)
NC410 (0)
OCV C01 (0)
PGV-001 (0)
PV-001-DC (0)
RTX-321 (0)
SQZ-PBMC-HPV (0)
TBX-3400 (0)
tabelecleucel (0)
SB-313 (0)
AGI-134 (0)
S-588410 (0)
TBI-1401 (0)
mouse TYRP2 DNA (0)
tretinoin (6)
DOC1021 (1)
INO-5401 (1)
GL-ONC1 (1)
cytotoxic lymphocyte-based cancer vaccine (0)
CRX100 (0)
EO2401 (0)
EO2463 (0)
ET140203 (0)
GRANITE (0)
GSK2130579A (0)
GSK2302025A (0)
GX301 (0)
HA-1 T TCR T Cell Immunotherapy (0)
HSV G207 (0)
IMA-901 (0)
IMA910 (0)
MT-201 (0)
NC410 (0)
OCV C01 (0)
PGV-001 (0)
PV-001-DC (0)
RTX-321 (0)
SQZ-PBMC-HPV (0)
TBX-3400 (0)
tabelecleucel (0)
SB-313 (0)
AGI-134 (0)
S-588410 (0)
TBI-1401 (0)
mouse TYRP2 DNA (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
IDH1 mutation + ATRX deletion + TP53 deletion
Glioma
IDH1 mutation + ATRX deletion + TP53 deletion
Glioma
CAN-3110
Sensitive: D – Preclinical
CAN-3110
Sensitive
:
D
CAN-3110
Sensitive: D – Preclinical
CAN-3110
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login